Finistère

Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership

Retrieved on: 
Monday, March 28, 2022
TASE, Company, Migros, Private Securities Litigation Reform Act, Therapy, Regenerative medicine, LinkedIn, Method, Tempo, Sale, Marketing, Wind, Legislation, Pressure, CEO, Bell, Israel Innovation Authority, U.S. Securities and Exchange Commission, CVC, Food industry, Nasdaq MarketSite, Fresh Start, Technology, Knowledge, Inflammation, Nasdaq, Finistère, GLOBE, Science, Tnuva, R, Closing Bell, Engineering, Security (finance), Online gambling, Fine chemical, Pharmaceutical industry, Pluristem Therapeutics

HAIFA, Israel, March 28, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI) (“Pluristem”), a leading biotechnology company, and Tnuva Group (“Tnuva Group” or “Tnuva”), Israel’s largest food producer, today announced that Pluristem’s CEO and President Yaky Yanay and Tnuva Group’s Chairman, Haim Gavrieli, will ring the Closing Bell at Nasdaq MarketSite in Times Square, New York. The ceremony, in honor of the companies’ launch of an innovative collaboration to develop, manufacture and commercialize cultured cell-based products for the food industry, will take place on Monday, March 28, 2022 at 3:45 pm ET.

Key Points: 
  • We are honored to celebrate this important collaboration between Pluristem and Tnuva at Nasdaq, said Yaky Yanay, CEO and President of Pluristem.
  • Over the years, Pluristem has developed one of the most advanced cell-based technology platforms, offering mass-scale, cost-effective, consistent cell production.
  • Haim Gavrieli, Chairman of Tnuva Group: I am excited to note the groundbreaking collaboration between Pluristem and Tnuva Group.
  • Pluristem (Nasdaq: PSTI) is pushing the boundaries of science and engineering to produce cell-based products for various industries on a global scale.

Pluristem and Tnuva Appoint Food Tech Veteran Eyal Rosenthal as Chief Executive Officer of their New Joint Venture

Retrieved on: 
Tuesday, March 8, 2022
Private Securities Litigation Reform Act, World Bank Group, Leadership, Regenerative medicine, Industry, Science, Security (finance), U.S. Securities and Exchange Commission, Israel Innovation Authority, Fresh Start, Knowledge, International Finance Corporation, Tnuva, Therapy, Growth, Method, Map, Migros, Legislation, Sale, Head, Infinity Group, Food, Inflammation, Marketing, TASE, Science and technology in Asia, Agriculture, CVC, Placenta, Finistère, Intellectual property, Engineering, Technology, R, Pressure, Nasdaq, Rosenthal, Meat, GLOBE, Tempo, Renewable energy, Fine chemical, Pluristem Therapeutics

Mr. Rosenthal also served as Executive Chairman of Fresh Start, a leading global food tech incubator backed by the Israel Innovation Authority, as well as top strategic and financial players.

Key Points: 
  • Mr. Rosenthal also served as Executive Chairman of Fresh Start, a leading global food tech incubator backed by the Israel Innovation Authority, as well as top strategic and financial players.
  • Food tech is on the rise and I am excited to be joining this new venture as we aim to transform the food system, especially the way we produce meat, said Mr. Rosenthal.
  • We believe that Eyal will position us as a leader in the global food tech industry, said Yaky Yanay, Chief Executive Officer and President of Pluristem.
  • Eyal is a food tech veteran and has an impressive track record as a trailblazer in the industry, said Eyal Malis, Chief Executive Officer of Tnuva Group.

Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food Platform

Retrieved on: 
Thursday, February 24, 2022
GLOBE, Dairy, Partnership, Israel Innovation Authority, Method, Wind, Intellectual property, Inflammation, Security (finance), Regenerative medicine, Food industry, Private Securities Litigation Reform Act, TASE, U.S. Securities and Exchange Commission, Finistère, Egg, Meat, Science, Pressure, Nasdaq, Engineering, Technology, Placenta, Knowledge, Legislation, CEO, Fine chemical, Life insurance, Pharmaceutical industry, Food delivery, NewCo, Pluristem Therapeutics, Tnuva

The collaboration is a major step forward to bringing sustainable cultured food to everyday consumers globally.

Key Points: 
  • The collaboration is a major step forward to bringing sustainable cultured food to everyday consumers globally.
  • Tnuva Group is the largest food producer in Israel, as well as the Israeli leader in the field of alternative dairy and protein products.
  • Tnuva holds Israels leading and most loved food brands in Israel, with approximately 4 million of Tnuva Groups products sold daily.
  • The collaboration with Tnuva supports Pluristems strategy to establish partnerships leveraging Pluristems cell-based technology platform.

Biotechnology Company Pluristem, and Israel’s Largest Food Producer Tnuva, Launch Landmark Collaboration to Establish Cultured Food Platform

Retrieved on: 
Monday, January 10, 2022
Knowledge, TASE, Party, Dairy, Intention, Migros, Israel Innovation Authority, Meat, Legislation, Concept, EST, Industry, Engineering, Security (finance), Method, Marketing, U.S. Securities and Exchange Commission, Food industry, Science, Regenerative medicine, Finistère, Research, Therapy, R, Pressure, CEO, IST, Company, Ischemia, Private Securities Litigation Reform Act, Nasdaq, Technology, Egg, Placenta, Intellectual property, Wind, GLOBE, Proof of concept, Food, Inflammation, Fine chemical, 3D printing, Risk management, Tnuva, Pluristem Therapeutics, NewCo

As part of the collaboration, the Parties may expand the collaboration to include cultured dairy and cultured fish products by establishing separate, new ventures.

Key Points: 
  • As part of the collaboration, the Parties may expand the collaboration to include cultured dairy and cultured fish products by establishing separate, new ventures.
  • Haim Gavrieli, Chairman of Tnuva Group: Our collaboration with Pluristem is part of the execution of Tnuva Groups strategy and vision.
  • We expect the collaboration between the companies to revolutionize the cultured food industry and develop the next generation of alternative proteins.
  • The collaboration with Tnuva supports Pluristem's strategy to establish partnerships that leverage its cell-based technology platform.